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STUDIES ON THE INFLUENCE OF OPERATIVE PROCEDURE 
UPON THE PLASMIN AND PLASMIN INHIBITOR ACTIVITY 
by 
HIROSHI TAKAGI 
Department of Surgery, Toho University, School of medicine 
(Director: Prof. SABURO AwAzu) 
The operation in a large scale and the great amount of blood transfusion or 
of infusion which have been undergoing recently, brought up, on the other hand, 
the danger of increased tendency of bleeding and of thrombus formation. 
We studied the change of plasmin content, fibrinolytic enzym, in patients pre-
and post-operatively by the modified MAcF ARLANE’s method, viscosimetry and the 
heated plate method. 
Inactive plasminogen was activated by streptkinase and plasmin inhibitor was 
measured indirectly by adding a certain amount of plasmin. 
The result obtained are as follows : 
1) As the result of observation by modified MAcFARLANE’s method, the trans司
fusion of restored blood produces fibrinolytic phenomenon remerkably, as compared 
with fresh blood transfusion. 
2) Fibrinolytic phenomenon are also produced by the operative procedure 
remarkably. This increased fibrinolysis was inhibited moderately by the pre・oprative
usage of wintamin (chloropromazin). 
3) Plasmin value measured by viscosimetry in normal individuals are less 
than 1.0 sec. The plasmin value by this method showed high level in patients 
during operation or post-operative period. This increased tendency was observed by 
the heated plat怠 methodas well. 
4) The value of total plasminogen including active plasmin does not show 
remarkable changes in most cases pre引 ldpost-operatively but it showed slight 
increased level after operation. 
5) Inhibitory factors including antiplasmin depressed plasmin activity post-
operatively. This inhibitory action was observed in 46% of al post-operative 



























































Inhibitor・・・ Plasminogen －→Plasm in・・ Inhibitor 
↑ 
Plasminogen Trypsin －－－… 一・・ .. Inhibitor 
Activator Chloroform 
Tissue Activator・ .. . ・Inhibitor 
Activator in blood, milk, tear .・Inhibitor 
Activator in Urine －－ー...Inhibitor 
1-S ontane Activator 
Lysokinase I SK ... ・… ・ー 一……Inhibitor1sゆ y凶 nぉe ・Inh仙 r
Kinase in blood ・司ー 一・Inhibitor 
I Tissue Kinase 
Proactivator in blood, milk, Tear 
手術の際に血中の Plasminが増加するのは
I. (general process）臓器中のTissuelysokinase 
が遊灘して血液中に入り，それによって血液中の
Proactivatorが ActiYatorに変化しP その Activ-
a torによって PlasminogenがPlasminに変化する．
2. (local process）臓器の Activator.が直接，血


































































































































に示すように7例中2例に完全溶解 I 70 i;o回初 3D空0JO 併時吋 1020 30初叩 fiO'ID 
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反って術後に溶解速度の減少を示した． 如く 17例中12例に術後に溶解面積の増加を示し＇ 5例
3) heated Plate methodに依る手術の Plas・ に逆に溶解面積の減少を示している．しかし増加した
min Plasminog-en, Inhibitor ！こ及ぼす影響 ものにあっても大部分はその増加の程度は2倦迄に止
al Plasmin まっており＇ 12例中7例は1.5倍迄の増加となってい
本法に於ては対照として一定単位！6:2(1 ！げ｝のTryp- る．以上のことはViscosime tryによるPlasminogen
sin溶液を滴下しp その面積を標準とした・第IO表に の活性化にもとづく totalActivityの変動とよく一致
しておりp Plasminogenは Streptokinaseによる活
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Astrup & Milertyにより認められた heatedplate 
methodにftえれば24例， 全例に術後に溶解面積の増大
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